New case studies published to TSBM website
The Translational Science Benefits Model website features two new case studies illustrating how research teams have used the TSBM in their research to highlight both the demonstrated and potential impact of their work. Using 3D Holograms to Treat Cardiac Arrhythmia—Developing and using 3D hologram technology (ELVIS) to guide physicians during cardiac ablation procedures. Advancing the […]
WashU Med study shows how COVID-19 increases risk of pregnancy complications
A new study by WashU Med maternal-fetal medicine researchers shows that the novel coronavirus infects maternal and fetal cells in the placenta and alters the balance of hormones that regulate blood pressure. This finding, published in the journal Med, helps explain why coronavirus infection has been linked to serious pregnancy complications, such as preeclampsia, that […]
Podcast: A year later, scientists recall efforts to jump-start research into mysterious new coronavirus (Links to an external site)
This episode of ‘Show Me the Science’ details how School of Medicine scientists began working with the virus, ramping up research efforts while the rest of the world was shutting down
For breastfeeding moms, COVID-19 vaccinations may also protect babies (Links to an external site)
Major boost in COVID-19 antibodies seen in breast milk after vaccination
N3C Data Enclave now includes data from more than 1 million COVID-positive patients
The National COVID Cohort Collaborative (N3C) Data Enclave is a one-of-a-kind collection of clinical data that the research community can use to study COVID-19 and identify potential treatments. It now has data derived from electronic health records of more than 4 million people, including more than 1 million patients who tested positive for COVID-19. Researchers […]
Anti-Depressant may help treat COVID-19 (Links to an external site)
In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine have found that the anti-depressant drug fluvoxamine seems to prevent some of the most serious complications of the illness, and makes hospitalization and the need for supplemental oxygen less likely.
Scientists find genetic link to clogged arteries (Links to an external site)
Independent of cholesterol, gene variants raise risk of heart disease, diabetes, high blood pressure
Joyce (Joy) Balls-Berry, PhD, MPE, elected to the Association for Clinical and Translational Science (ACTS) Board of Directors
Joyce (Joy) Balls-Berry, PhD, MPE, Associate Professor of Neurology, Lead, Knight ADRC Health Disparities and Equity Core, Washington University in St. Louis, was recently elected to the Association for Clinical and Translational Science (ACTS) Board of Directors. The Association for Clinical and Translational Science (ACTS) was founded in 2009 to support the needs of the […]
Promising role for whole genome sequencing in guiding blood cancer treatment (Links to an external site)
Sequencing results returned in a few days; costs similar to conventional testing
Engaging special populations with community and investigator partnerships; ICTS provides framework for unique collaboration to develop and thrive
A Relationship Begins One could say she has community in her heart. Rev. Dr. Paulette Sankofa, EdD, grew up in the St. Louis West End and remembers the tight community connections, particularly among older adults that was commonplace at that time. It is this sense of community and respect for seniors instilled as a young […]
ICTS investigators featured on 60 Minutes discussing their study using fluvoxamine to treat COVID patients
New evidence COVID-19 antibodies, vaccines less effective against variants (Links to an external site)
Worrisome new coronavirus variants can evade antibodies that neutralize original virus
Opioid overdose reduced in patients taking buprenorphine (Links to an external site)
Study indicates the drug is effective in opioid users who also take benzodiazepines for anxiety, other conditions
Saint Louis University ICTS investigator utilizes funding mechanism to advance research on opioid therapy options
Neuropathic pain affects millions of Americans every year. This fact combined with the nationwide crisis of opioid misuse reinforces the need for safer and more effective therapies to help those suffering from chronic pain. In tandem with efforts from the National Center for Advancing Translational Sciences and in an effort to advance research in this […]
ICTS investigators featured on RADx-UP website
ICTS Associate Director Christina Gurnett, MD, PhD and ICTS investigator Jason Newland, MD are featured on the RADx-UP website in a video detailing the COMPASS-T project that works to improve school safety by providing routine COVID-19 testing to staff and students in the Special School District of St. Louis. The National Institutes of Health (NIH) […]
ICTS Announces 2021-2022 CTRFP Awardees
Washington University Institute of Clinical and Translational Sciences (ICTS) and The Foundation for Barnes-Jewish Hospital awards 17 investigators as part of the 14th annual Clinical and Translational Research Funding Program (CTRFP). The CTRFP is the largest internal grant funding program of the ICTS. Applicants are required to submit proposals for projects that promote the translation […]
The race to treat a rare, fatal syndrome may help others with common disorders like diabetes (Links to an external site)
COVID-19 vaccines at Washington University School of Medicine
Combating COVID-19 (Links to an external site)
Medical school labs pivot to fight a common enemy
ICTS investigators test fluvoxamine repurposed as treatment for COVID, Utilize fully-remote clinical trial to reach participants
The proverbial saying ‘Necessity is the mother of invention’ is frequently used to explain how great innovations are made during times of urgent need. Never has the need been direr than when the COVID pandemic hit in March 2020 and health care providers were struggling to find treatments for patients fighting this new and deadly […]
Rapid blood test identifies COVID-19 patients at high risk of severe disease (Links to an external site)
Measuring mitochondrial DNA could predict who will need ICU care, intubation
ICTS investigators featured in National Institute of General Medical Sciences blog
January 13 blogpost, “Fight Against COVID-19 Aided by Sepsis Researchers” features Richard Hotchkiss, MD and Kenneth Remy, MD. Read the entire blog post here.
Doctors test popular anti-depressant to see if it fights off Covid-19 (Links to an external site)
Fauci gives COVID-19 update to School of Medicine faculty, staff, students (Links to an external site)
Virtual talk also open to general public
Fauci to discuss COVID-19 during online med school event Jan. 7 (Links to an external site)
Lecture hosted by Department of Medicine will be available online to public






















